Clinical trial
Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)
NCT04589208 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- January 1, 2021
- Completion date
- April 1, 2027
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy